Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00021996 · ClinicalTrials.gov registry record · NA
Valdecoxib in Treating Chronic Pain in Cancer Patients
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
NCT00021996: Completed NA study, sponsored by Dana-Farber Cancer Institute.
NCT00021996 is a NA study that has completed, run by Dana-Farber Cancer Institute. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00021996, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Valdecoxib may be effective in relieving chronic pain in cancer patients. It is not yet known if valdecoxib is effective in treating chronic pain. PURPOSE: Randomized clinical trial to study the effectiveness of valdecoxib in relieving chronic pain in cancer patients.
Interventions
- DRUG valdecoxib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2004-02 |
| Phase | NA |
What the finished NCT00021996 record still lists
NCT00021996 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which valdecoxib is the first listed.
NCT00021996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00021996 about?
NCT00021996 is a clinical study titled "Valdecoxib in Treating Chronic Pain in Cancer Patients". RATIONALE: Valdecoxib may be effective in relieving chronic pain in cancer patients. It is not yet known if valdecoxib is effective in treating chronic pain. PURPOSE: Randomized clinical trial to study the effectiveness of valdecoxib in relieving chronic pain in cancer patients.
What is the current status of trial NCT00021996?
This trial is currently completed. It is a NA study. The study started on 2001-01. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00021996?
The interventions under investigation include: valdecoxib (DRUG).
Who is sponsoring clinical trial NCT00021996?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia